-
Prince Harry and family to stay at royal residences on UK visit
-
Wimbledon 'towel thief' Swiatek back on the trophy hunt
-
'Why not?': Cape Verde eye seismic World Cup shock against Argentina
-
Venezuela earthquake deaths near 1,000, with millions more in need
-
Russell snatches controversial pole in Austria after Verstappen crash
-
French Open champs head to Wimbledon wrestling with new-found status
-
Davidovich Fokina wins in Mallorca for first ATP title
-
Budapest Pride marchers push for equality after reversed ban
-
Sabalenka urges Grand Slams to 'get it done' in prize money boycott row
-
Russell snatches pole, Antonelli fourth for Austria GP grid
-
Russell snatches pole as Verstappen, Antonelli fourth for Austria GP grid
-
Broos smiles and snarls before South Africa's historic World Cup match
-
Newborn baby rescued from rubble of Venezuela quake
-
Supersub Foulkes strike for New Zealand in England finale
-
Raducanu halts practice session to put Wimbledon bid in doubt
-
Wolff says Russell will be at Mercedes next season
-
Keys beats Maria to clinch third Eastbourne title
-
Djokovic inspired by Serena as he targets history at Wimbledon
-
Thousands ride through Rome as Vespa celebrates 80 years
-
Stokes falls cheaply as England collapse in New Zealand decider
-
Sinner ready for Wimbledon defence despite lack of time on grass
-
Russell bounces back to beat Antonelli in final practice
-
Records tumble as European heatwave moves east
-
England, Portugal eye top spots as World Cup group stages wrap up
-
Injured Australian pair Leckie, Italiano out of World Cup
-
Farmers fear drought as Italy's longest river runs dry
-
Thousands expected as Vespa celebrates 80 years in Rome
-
Budapest Pride to push for equality after reversed ban
-
Pino, Williams injuries mar Spain's World Cup progress
-
World Cup fans get taste of American life -- at the mall
-
'Struggle continues' in Bolivia's Morales heartland
-
World Cup turns New York's Times Square into global fan hub
-
Bielsa accepts blame for World Cup exit, but says Uruguay deserved more
-
Lebanon, Israel and US sign trilateral framework pact
-
Uruguay crash out of World Cup as Spain avoid Argentina clash
-
Cape Verde extend World Cup fairytale to set up Argentina meeting
-
Swiss glaciers facing drastic loss from heatwave: expert
-
Messi to start dead-rubber World Cup group match on bench
-
Trump unveils new US passport -- with picture of himself
-
Hat-trick hero Dembele displays Ballon d'Or brilliance for France at World Cup
-
Maple Leafs make teen McKenna top pick in NHL Draft
-
Injured England defender James to miss Panama game at World Cup
-
California appeals court orders Weinstein resentencing for sex assault
-
Norway coach defends decision to leave out Haaland, Odegaard against France
-
Scheffler fires 60 to grab 36-hole PGA Travelers lead
-
Movie theaters are allies for streamers like us, Apple exec says
-
Austria's Rangnick shuts down conspiracy talk ahead of Algeria World Cup clash
-
DR Congo must take risks to keep World Cup 'dream alive', says Desabre
-
Should we fear an AI bubble bust?
-
Jangoo, Chase keep West Indies in touch against Sri Lanka
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
Ferreira--PC